Syra
Health Corp.
1110
Keystone Way N. #201
Carmel,
IN 46032
September
29, 2026
VIA
EDGAR
United
States Securities and Exchange Commission
100
F. Street, NE
Washington,
DC 20549
| |
Re: |
Syra
Health Corp. |
| |
|
Withdrawal
of Registration Statement on Form S-1 |
| |
|
File
No. 333-298924 |
Dear
Ladies and Gentlemen:
Pursuant
to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), Syra Health Corp. (the “Registrant”)
hereby requests the immediate withdrawal of the above-referenced registration statement, together with all exhibits and amendments thereto
(the “Registration Statement”). The Registration Statement was initially filed with the Securities and Exchange Commission
(the “SEC”) on September 14, 2026.
The
Registrant is requesting to withdraw the Registration Statement because it has elected to register the shares of common stock underlying
the warrants on Form S-1, as a post-effective amendment to registration statement on Form S-1 (File No. 333-281583) filed with the SEC
on August 15, 2024, and declared effective on September 12, 2024. The Registrant confirms the Registration Statement was never declared
effective and that no securities were sold for resale as contemplated by the Registration Statement.
Please
direct any questions or comments regarding this correspondence to our counsel, Jeffrey J. Fessler of Sheppard Mullin Richter & Hampton
LLP, at (212) 653-8700.
Thank
you for your assistance in this matter.
| |
Sincerely, |
| |
|
|
| |
Syra
Health Corp. |
| |
|
|
| |
/s/
Gregory R. Alexander |
| |
Gregory
R. Alexander |
| |
Chief
Executive Officer |
